(Q40801796)

English

Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose (English)

1 reference

Europe PubMed Central

23 September 2017

0 references

0 references

Plasmodium falciparum

0 references

1 reference

based on heuristic

inferred from title

author name string

Harinasuta T

1

1 reference

Europe PubMed Central

23 September 2017

Bunnag D

2

1 reference

Europe PubMed Central

23 September 2017

Vanijanond S

3

1 reference

Europe PubMed Central

23 September 2017

Charoenlarp P

4

1 reference

Europe PubMed Central

23 September 2017

Suntharasmai P

5

1 reference

Europe PubMed Central

23 September 2017

Chitamas S

6

1 reference

Europe PubMed Central

23 September 2017

Sheth UK

7

1 reference

Europe PubMed Central

23 September 2017

Wernsdorfer WH

8

1 reference

Europe PubMed Central

23 September 2017

language of work or name

0 references

publication date

1 January 1987

1 reference

Europe PubMed Central

23 September 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

Bulletin of the World Health Organization

1 reference

Europe PubMed Central

23 September 2017

65

1 reference

Europe PubMed Central

23 September 2017

363-367

1 reference

Europe PubMed Central

23 September 2017

3

1 reference

Europe PubMed Central

23 September 2017

Decrease in susceptibility of Plasmodium falciparum to mefloquine in continuous culture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2490999

24 September 2017

Plasmodium malaria resistant to chloroquine in a Zambian living in Zambia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2490999

24 September 2017

A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2490999

24 September 2017

A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2490999

24 September 2017

The chemotherapy of rodent malaria XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2490999

15 June 2018

In vitro mefloquine resistant Plasmodium falciparum from the Philippines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2490999

15 June 2018

Mefloquine-pyrimethamine-sulfadoxine combination delays emergence of mefloquine resistant Plasmodium falciparum in continuous culture.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2490999

19 August 2018

Identifiers

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40801796&oldid=1907650020"